349 related articles for article (PubMed ID: 24463215)
21. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
[TBL] [Abstract][Full Text] [Related]
22. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
[TBL] [Abstract][Full Text] [Related]
23. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
24. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
Suzukawa K; Parganas E; Gajjar A; Abe T; Takahashi S; Tani K; Asano S; Asou H; Kamada N; Yokota J
Blood; 1994 Oct; 84(8):2681-8. PubMed ID: 7919381
[TBL] [Abstract][Full Text] [Related]
25. Double Inv(3)(q21q26), a rare but recurrent chromosomal abnormality in myeloid hemopathies.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Ianotto JC; Berthou C; Gueganic N; Bovo C; Basinko A; Morel F; De Braekeleer M
Anticancer Res; 2013 Feb; 33(2):639-42. PubMed ID: 23393360
[TBL] [Abstract][Full Text] [Related]
26. [Clinical and laboratory investigation of hematological malignancy patients carrying 3q21q26 rearrangement].
Xu FY; Liu XP; Qin S; Li CW; Lin D; Mi YC; Liu SH; Wang JX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):696-8. PubMed ID: 18067087
[TBL] [Abstract][Full Text] [Related]
27. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study.
Secker-Walker LM; Mehta A; Bain B
Br J Haematol; 1995 Oct; 91(2):490-501. PubMed ID: 8547101
[TBL] [Abstract][Full Text] [Related]
28. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.
Kayser S; Zucknick M; Döhner K; Krauter J; Köhne CH; Horst HA; Held G; von Lilienfeld-Toal M; Wilhelm S; Rummel M; Germing U; Götze K; Nachbaur D; Schlegelberger B; Göhring G; Späth D; Morlok C; Teleanu V; Ganser A; Döhner H; Schlenk RF;
Blood; 2012 Jan; 119(2):551-8. PubMed ID: 22096250
[TBL] [Abstract][Full Text] [Related]
29. Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system.
Schanz J; Steidl C; Fonatsch C; Pfeilstöcker M; Nösslinger T; Tuechler H; Valent P; Hildebrandt B; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Garcia-Manero G; Kantarjian H; Germing U; Haase D; Estey E
J Clin Oncol; 2011 May; 29(15):1963-70. PubMed ID: 21519021
[TBL] [Abstract][Full Text] [Related]
30. Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
Deeg HJ; Scott BL; Fang M; Shulman HM; Gyurkocza B; Myerson D; Pagel JM; Platzbecker U; Ramakrishnan A; Radich JP; Sandmaier BM; Sorror M; Stirewalt DL; Wilson WA; Storb R; Appelbaum FR; Gooley T
Blood; 2012 Aug; 120(7):1398-408. PubMed ID: 22767498
[TBL] [Abstract][Full Text] [Related]
31. Translocation (3;6)(q21;p21) in acute myeloid leukemia with abnormal thrombopoiesis and basophilia.
Hoyle CF; Sherrington P; Hayhoe FG
Cancer Genet Cytogenet; 1988 Feb; 30(2):261-7. PubMed ID: 3422580
[TBL] [Abstract][Full Text] [Related]
32. [Acute myeloid leukemia with monosomy 7 and inv(3)(q21q26.2) complicated with central diabetes insipidus].
Nanno S; Hagihara K; Sakabe M; Okamura H; Inaba A; Nagata Y; Nishimoto M; Koh H; Nakao Y; Nakane T; Nakamae H; Shimono T; Hino M
Rinsho Ketsueki; 2013 Apr; 54(4):397-402. PubMed ID: 23666224
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia.
Courville EL; Wu Y; Kourda J; Roth CG; Brockmann J; Muzikansky A; Fathi AT; de Leval L; Orazi A; Hasserjian RP
Mod Pathol; 2013 Jun; 26(6):751-61. PubMed ID: 23307061
[TBL] [Abstract][Full Text] [Related]
34. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome.
Valcárcel D; Ademà V; Solé F; Ortega M; Nomdedeu B; Sanz G; Luño E; Cañizo C; de la Serna J; Ardanaz M; Marco V; Collado R; Grau J; Montoro J; Mallo M; Vallespí T
J Clin Oncol; 2013 Mar; 31(7):916-22. PubMed ID: 23319689
[TBL] [Abstract][Full Text] [Related]
35. Unusual blasts with basophilic granules in 2 cases of de novo acute myeloid leukemia with inv3(q21q26.2) and monosomy 7 and coexpression of CD2 and CD31.
Treaba DO; Chaump M; Merriam P; Ferreira K; Souza L; Winer ES; Barker BE
Ann Diagn Pathol; 2014 Feb; 18(1):33-40. PubMed ID: 23896391
[TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia secondary to a myelodysplastic syndrome with t(3;3) (q21;q26) in an HIV patient treated with chemotherapy and highly active antiretroviral therapy.
Breccia M; Gentile G; Martino P; Petti MC; Russo E; Mancini M; Alimena G
Acta Haematol; 2004; 111(3):160-2. PubMed ID: 15034238
[TBL] [Abstract][Full Text] [Related]
37. Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.
Falantes JF; Calderón C; Márquez Malaver FJ; Alonso D; Martín Noya A; Carrillo E; Martino ML; Montero I; González J; Parody R; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):144-52. PubMed ID: 23137720
[TBL] [Abstract][Full Text] [Related]
38. t(3;5)(q21;q31) in a myelodysplastic syndrome.
Sharp RA; Robertson J; Heppleston AD
Leuk Res; 1987; 11(7):629-33. PubMed ID: 3475514
[TBL] [Abstract][Full Text] [Related]
39. Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies.
Shi G; Weh HJ; Dührsen U; Zeller W; Hossfeld DK
Cancer Genet Cytogenet; 1997 Jul; 96(1):58-63. PubMed ID: 9209472
[TBL] [Abstract][Full Text] [Related]
40. inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Schmidt HH; Pirc-Danoewinata H; Linkesch W; Strunk D; Wieser R
Haematologica; 2003 Dec; 88(12):ECR38. PubMed ID: 14688011
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
